What if the Media Reported on Prescription Drugs Like They Do on Cannabis?

The New York Times’ recent cannabis coverage leans on cherry-picked data and fear-driven narratives—here’s why that matters.

Dr C: In this piece, journalist Hannah Harris Green takes a deep dive into the New York Times’ latest coverage on cannabis harms, challenging its selective use of statistics and its portrayal of cannabis-related risks. With her background in cannabis science and policy, Hannah brings a fresh perspective, questioning why mainstream media often focuses on alarm rather than accuracy. This cross-post from her new newsletter, Indispensable, is a call for a more nuanced and honest conversation around cannabis—one that respects both science and the real-life experiences of patients. More info at the end.